224 related articles for article (PubMed ID: 32523628)
61. Recurrent disease following endoscopic ablation of Barrett's high-grade dysplasia with spray cryotherapy.
Halsey KD; Chang JW; Waldt A; Greenwald BD
Endoscopy; 2011 Oct; 43(10):844-8. PubMed ID: 21826629
[TBL] [Abstract][Full Text] [Related]
62. New directions in endoscopic therapy of Barrett' s esophagus.
Konda Vani JA; Chennat J; Waxman I
Minerva Gastroenterol Dietol; 2010 Dec; 56(4):421-35. PubMed ID: 21139541
[TBL] [Abstract][Full Text] [Related]
63. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.
van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ
Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412
[TBL] [Abstract][Full Text] [Related]
64. Esophagectomy for Barrett's esophagus: indications, techniques, and outcome.
Nguyen NT; Chang K; Nahidi T; Wilson SE; Luketich JD
Curr Treat Options Gastroenterol; 2006 Feb; 9(1):85-92. PubMed ID: 16423317
[TBL] [Abstract][Full Text] [Related]
65. Mucosal Ablation Techniques for Barrett's Esophagus and Early Esophageal Cancer.
Rajaram R; Hofstetter WL
Thorac Surg Clin; 2018 Nov; 28(4):473-480. PubMed ID: 30268293
[TBL] [Abstract][Full Text] [Related]
66. Endoscopic Treatment of High-Grade Dysplasia and Early Esophageal Cancer.
Schlottmann F; Patti MG; Shaheen NJ
World J Surg; 2017 Jul; 41(7):1705-1711. PubMed ID: 28275832
[TBL] [Abstract][Full Text] [Related]
67. Recurrence of subsquamous dysplasia and carcinoma after successful endoscopic and radiofrequency ablation therapy for dysplastic Barrett's esophagus.
Lee JK; Cameron RG; Binmoeller KF; Shah JN; Shergill A; Garcia-Kennedy R; Bhat YM
Endoscopy; 2013 Jul; 45(7):571-4. PubMed ID: 23592390
[TBL] [Abstract][Full Text] [Related]
68. Recurrence of Barrett's Esophagus is Rare Following Endoscopic Eradication Therapy Coupled With Effective Reflux Control.
Komanduri S; Kahrilas PJ; Krishnan K; McGorisk T; Bidari K; Grande D; Keefer L; Pandolfino J
Am J Gastroenterol; 2017 Apr; 112(4):556-566. PubMed ID: 28195178
[TBL] [Abstract][Full Text] [Related]
69. Surgical management of Barrett's esophagus.
Clark GW; DeMeester TR
Ann Chir Gynaecol; 1995; 84(2):139-44. PubMed ID: 7574371
[TBL] [Abstract][Full Text] [Related]
70. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus.
Levine DS; Haggitt RC; Blount PL; Rabinovitch PS; Rusch VW; Reid BJ
Gastroenterology; 1993 Jul; 105(1):40-50. PubMed ID: 8514061
[TBL] [Abstract][Full Text] [Related]
71. Current state of endoscopic therapies in Barrett's esophagus and esophageal cancer.
Hudson M; Lin CL; Habr F
Hosp Pract (1995); 2011 Feb; 39(1):170-80. PubMed ID: 21441773
[TBL] [Abstract][Full Text] [Related]
72. Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study.
Phoa KN; Pouw RE; van Vilsteren FGI; Sondermeijer CMT; Ten Kate FJW; Visser M; Meijer SL; van Berge Henegouwen MI; Weusten BLAM; Schoon EJ; Mallant-Hent RC; Bergman JJGHM
Gastroenterology; 2013 Jul; 145(1):96-104. PubMed ID: 23542068
[TBL] [Abstract][Full Text] [Related]
73. Polypoid Dysplasia in Barrett's Esophagus: Diagnosis, Management, and Very Different Outcomes in Two Consecutive Cases.
Murphy M; Tofani C; Gandhi K; Infantolino A
Case Rep Gastrointest Med; 2016; 2016():8421531. PubMed ID: 27999692
[No Abstract] [Full Text] [Related]
74. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus.
Attwood SE; Lewis CJ; Caplin S; Hemming K; Armstrong G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):258-63. PubMed ID: 15017666
[TBL] [Abstract][Full Text] [Related]
75. Mucosal Ablation in Patients with Barrett's Esophagus: Fry or Freeze?
Visrodia K; Zakko L; Wang KK
Dig Dis Sci; 2018 Aug; 63(8):2129-2135. PubMed ID: 29777441
[TBL] [Abstract][Full Text] [Related]
76. Quality Indicators in Endoscopic Ablation for Barrett's Esophagus.
Han S; Wani S
Curr Treat Options Gastroenterol; 2017 Jun; 15(2):241-255. PubMed ID: 28421454
[TBL] [Abstract][Full Text] [Related]
77. Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma.
Weston AP; Sharma P
Am J Gastroenterol; 2002 Dec; 97(12):2998-3006. PubMed ID: 12492182
[TBL] [Abstract][Full Text] [Related]
78. Management of Post Ablative Barrett's Esophagus: a Review of Current Practices and Look at Emerging Technologies.
Davis C; Kolb JM
Curr Treat Options Gastroenterol; 2023; 21(2):125-137. PubMed ID: 37284351
[TBL] [Abstract][Full Text] [Related]
79. Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients.
Pouw RE; Seewald S; Gondrie JJ; Deprez PH; Piessevaux H; Pohl H; Rösch T; Soehendra N; Bergman JJ
Gut; 2010 Sep; 59(9):1169-77. PubMed ID: 20525701
[TBL] [Abstract][Full Text] [Related]
80. Barrett's esophagus: best practices for treatment and post-treatment surveillance.
Mansour NM; El-Serag HB; Anandasabapathy S
Ann Cardiothorac Surg; 2017 Mar; 6(2):75-87. PubMed ID: 28446996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
